[1] |
World Health Organization: World malaria report 2018[M]. Geneva: WHO Press, 2018: 14-15.
|
[2] |
雷正龙, 王立英. 全国重点寄生虫病防治形势与主要任务[J]. 中国寄生虫学与寄生虫病杂志, 2012, 30(1): 1-5.
|
[3] |
张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J].中国寄生虫学与寄生虫病杂志, 2018, 36(3): 201-209.
|
[4] |
刘怀鄂, 苏品璨, 陈熙, 等. 常用抗间日疟药物抗药性机制研究进展[J]. 中国病原生物学杂志, 2018, 13(9): 1049-1051, 1053.
|
[5] |
牟畇珊, 李璐杰, 吴银娟, 等. 疟原虫青蒿素耐药分子机制探索[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(6): 636-642.
|
[6] |
Cowman AF, Healer J, Marapana D, et al. Malaria: biology and disease[J]. Cell, 2016, 167(3): 610-624.
|
[7] |
Goller JL, Jolley D, Ringwald P, et al. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy[J]. Am J Trop Med Hyg, 2007, 76(2): 203-207.
|
[8] |
Sinden RE.Developing transmission-blocking strategies for malaria control[J]. PLoS Pathog, 2017, 13(7): e1006336.
|
[9] |
Gatton ML, Chitnis N, Churcher T, et al. The importance of mosquito behavioural adaptations to malaria control in Africa[J]. Evolution, 2013, 67(4): 1218-1230.
|
[10] |
Cao Y, Bansal GP, Merino K, et al. Immunological cross-reactivity between malaria vaccine target antigen P48/45 in Plasmodium vivax and P. falciparum and cross-boosting of immune responses[J]. PLoS One, 2016, 11(7): e0158212.
|
[11] |
Marin-Mogollon C, van de Vegte-Bolmer M, van Gemert GJ, et al. The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission[J]. Sci Rep, 2018, 8(1): 14902.
|
[12] |
Blagborough AM, Musiychuk K, Bi H, et al. Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax[J]. Vaccine, 2016, 34(28): 3252-3259.
|
[13] |
Armistead JS, Morlais I, Mathias DK, et al. Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria[J]. Infect Immun, 2014, 82(2): 818-829.
|
[14] |
Draper SJ, Sack BK, King CR, et al. Malaria vaccines: recent advances and new horizons[J]. Cell Host Microbe, 2018, 24(1): 43-56.
|
[15] |
Ecker A, Bushell ES, Tewari R, et al. Reverse genetics screen identifies six proteins important for malaria development in the mosquito[J]. Mol Microbiol, 2008, 70(1): 209-220.
|
[16] |
李敏, 郑文琪, 何一雯, 等. 新型疟疾传播阻断疫苗候选抗原PbPSOP7基因截短片段的克隆及表达特点的研究[J]. 微生物学杂志, 2016, 36(4): 41-46.
|
[17] |
Malkin EM, Durbin AP, Diemert DJ, et al. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria[J]. Vaccine, 2005, 23(24): 3131-3138.
|
[18] |
Sala KA, Nishiura H, Upton LM, et al. The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro[J]. Vaccine, 2015, 33(3): 437-445.
|
[19] |
Zheng WQ, Kou X, Du YT, et al. Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei[J]. Vaccine, 2016, 34(23): 2570-2578.
|